Traders Buy High Volume of Call Options on Mylan N.V. (NASDAQ:MYL)

Mylan N.V. (NASDAQ:MYL) was the recipient of unusually large options trading activity on Thursday. Stock traders bought 18,942 call options on the company. This is an increase of 589% compared to the typical volume of 2,749 call options.

Mylan N.V. (NASDAQ:MYL) traded up 0.52% during trading on Friday, hitting $30.72. The company’s stock had a trading volume of 7,185,271 shares. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $49.09. The firm has a 50 day moving average of $36.12 and a 200 day moving average of $38.80. The firm has a market cap of $16.47 billion, a P/E ratio of 24.83 and a beta of 1.27.

Mylan N.V. (NASDAQ:MYL) last posted its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by $0.08. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The business had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the firm posted $1.16 earnings per share. Mylan N.V.’s quarterly revenue was up 15.7% on a year-over-year basis. Equities research analysts predict that Mylan N.V. will post $4.52 earnings per share for the current year.

MYL has been the subject of several recent analyst reports. Barclays PLC raised shares of Mylan N.V. from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $47.00 to $50.00 in a research report on Monday, May 22nd. BMO Capital Markets initiated coverage on shares of Mylan N.V. in a research report on Monday, May 1st. They set an “outperform” rating and a $50.00 price objective for the company. Cantor Fitzgerald initiated coverage on shares of Mylan N.V. in a research report on Friday, June 16th. They set a “neutral” rating and a $41.00 price objective for the company. Royal Bank Of Canada set a $41.00 price objective on shares of Mylan N.V. and gave the stock a “hold” rating in a research report on Sunday, July 16th. Finally, Zacks Investment Research cut shares of Mylan N.V. from a “hold” rating to a “sell” rating in a research report on Monday, May 15th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $47.73.

In other news, President Rajiv Malik sold 25,000 shares of the business’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $1,000,000.00. Following the completion of the sale, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Anthony Mauro sold 10,000 shares of the business’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the sale, the insider now directly owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the stock. First Personal Financial Services raised its stake in Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock valued at $107,000 after buying an additional 681 shares in the last quarter. Global X Management Co. LLC raised its stake in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after buying an additional 1,441 shares in the last quarter. Ropes Wealth Advisors LLC purchased a new stake in Mylan N.V. during the first quarter valued at $136,000. Oakworth Capital Inc. raised its stake in Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock valued at $166,000 after buying an additional 1,000 shares in the last quarter. Finally, State of Alaska Department of Revenue purchased a new stake in Mylan N.V. during the first quarter valued at $188,000. Institutional investors own 71.57% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.com-unik.info/2017/08/19/stock-traders-purchase-large-volume-of-mylan-n-v-call-options-nasdaqmyl-updated-updated-updated.html.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

What are top analysts saying about Mylan N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mylan N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit